Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
Eli Lilly to Invest $3.5 Billion in Lehigh Valley Manufacturing Site for Next-Generation Weight-Loss Medicines

The $3.5 billion Lehigh Valley site will develop Lilly's next-generation weight-loss medicines, including retatrutide Company plans to create more than ...

February 03, 2026 | Tuesday | News
Tenpoint Therapeutics Raises $235M in Series B Financing and Credit Facility to Support YUVEZZI Launch

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging...

January 30, 2026 | Friday | News
SK Capital to Divest Noramco API Assets to Siegfried as Halo Pharma Emerges as Stand-Alone Drug Product CDMO

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...

January 29, 2026 | Thursday | News
Gates Foundation, Novo Nordisk Foundation, and Wellcome Launch $60M Global Consortium to Accelerate Antibiotic Discovery Against AMR

The Gates Foundation, Novo Nordisk Foundation, and Wellcome today awarded a total of $60 million in new grant funding over the next three years to resear...

January 23, 2026 | Friday | News
Exciva GmbH Raises €51 Million Series B to Advance Phase 2 Program for Alzheimer’s Agitation Therapy

Exciva GmbH, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, today announces the closi...

January 22, 2026 | Thursday | News
AGC Biologics’ Milan Cell and Gene Center Strengthens Global Leadership with Waskyra™ Approval

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approved ...

January 20, 2026 | Tuesday | News
Apiject to Open 30,000-Square-Foot Pharmaceutical Manufacturing Facility in North Carolina

30,000-Square-Foot Facility Will Advance America's Priority to Reshore Essential Drug Manufacturing Apiject Holdings, Inc. announced the signing of a le...

January 19, 2026 | Monday | News
Stablepharma and AFT Pharmaceuticals Partner to Develop Fridge-Free Sterile Injectables for Global Markets

  Stablepharma Limited, specialists in thermostable formulations,announced a development and option-to-license agreement with AFT Pharmaceuticals to ...

January 16, 2026 | Friday | News
RISA Labs Raises $11.1M Series A to Scale AI Operating System for Oncology

RISA Labs, a company pioneering an AI operating system for oncology, announced the closing of an $11.1 million Series A funding round. The financing was ...

January 15, 2026 | Thursday | News
Lilly Bets on Chronic Inflammation With $1.2B All-Cash Acquisition of Ventyx

Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-based clinical-stage biopharmaceutical company focused on...

January 11, 2026 | Sunday | News
Nxera Pharma Secures APAC Rights to Vamorolone for Duchenne Muscular Dystrophy

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and China New...

January 09, 2026 | Friday | News
Sharp Sterile Advances Global Growth Strategy With $28M Lee Facility Expansion

Sharp Sterile Manufacturing has  announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will st...

January 09, 2026 | Friday | News
Amgen Acquires Dark Blue Therapeutics To Advance DBT 3757 For Acute Leukemia

  Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myelo...

January 08, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close